[Economic aspects. Cost-effectiveness, cost-benefit analysis].
Durieux
P
P
D001993:Bronchodilator Agents / Q000191:economics; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics; D005060:Europe; D005500:Follow-Up Studies; D017048:Health Care Costs; D006295:Health Resources / Q000191:economics; D006801:Humans; D007348:Insurance, Health / Q000145:classification; D008173:Lung Diseases, Obstructive / Q000191:economics* / Q000628:therapy; D011057:Politics; D011634:Public Health / Q000191:economics; D011788:Quality of Life; D015203:Reproducibility of Results; D012138:Respiratory Therapy / Q000191:economics
D001993:Bronchodilator Agents